Moulin, M; Anderton, H; Voss, A K; Thomas, T; Wong, W W L; Bankovacki, A; Feltham, R; Chau, D; Cook, W D; Silke, J; Vaux, D L (2012). IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality. EMBO Journal Online, 31(7):1679-1691.
Millet, P; Moulin, M; Stieger, B; Daali, Y; Pastor, C M (2011). How organic anions accumulate in hepatocytes lacking mrp2: evidence in rat liver. Journal of Pharmacology and Experimental Therapeutics, 336(3):624-632.
Gentle, I E; Wong, W W L; Evans, J M; Bankovacki, A; Cook, W D; Khan, N R; Nachbur, U; Rickard, J; Anderton, H; Moulin, M; Lluis, J M; Moujalled, D M; Silke, J; Vaux, D L (2011). In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. Journal of Biological Chemistry, 286(15):13282-13291.
Lluis, J M; Nachbur, U; Cook, W D; Gentle, I E; Moujalled, D; Moulin, M; Wong, W W L; Khan, N; Chau, D; Callus, B A; Vince, J E; Silke, J; Vaux, D L (2010). TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL. PLoS ONE, 5(1):e8620.
Geserick, P; Hupe, M; Moulin, M; Wong, W Wei-Lynn; Feoktistova, M; Kellert, B; Gollnick, H; Silke, J; Leverkus, M (2009). Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. Journal of Cell Biology, 187(7):1037-1054.